Clinical trialEPhase 1Not yet recruiting
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
Evaluation of the Distribution of CM500 in Healthy Volunteers and Patients With Cancer
- Outcome
- Ongoing
- Phase
- EPhase 1
- Status
- Not yet recruiting
- Study type
- Interventional
- Start
- 1 September 2026
- Expected end
- 1 September 2027
- Enrollment
- 40 participants
- Sites
- 3
- Primary outcomes
- Pharmacokinetics of the PET radiopharmaceuticals [64Cu]CM500 and [68Ga]CM500 in healthy volunteers through measurement of radioactivity in blood; Standardized uptake value; Dosimetry and radiation burden of [64Cu]CM500 and [68Ga]CM500
- Sponsor
- Industry
- Results posted
- No
- Last update
- 28 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try